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While prions probably interact with the innate immune system immediately following infection, little is
known about this initial confrontation. Here we investigated incunabular events in lymphotropic and
intranodalpriontraffickingbyfollowinghighlyenriched,fluorescentprionsfrominfectionsitestodraining
lymph nodes. We detected biphasic lymphotropic transport of prions from the initial entry site upon
peripheralprioninoculation.Prionsarrivedindraininglymphnodescellautonomouslywithintwohoursof
intraperitoneal administration. Monocytes and dendritic cells (DCs) required Complement for optimal
prion delivery to lymph nodes hours later in a second wave of prion trafficking. B cells constituted the
majority of prion-bearing cells in the mediastinal lymph node by six hours, indicating intranodal prion
reception from resident DCs or subcapsulary sinus macrophages or directly from follicular conduits. These
data reveal novel, cell autonomous prion lymphotropism, and a prominent role for B cells in intranodal
prion movement.
P
riondiseases,alsoknownastransmissiblespongiformencephalopathies(TSEs),arefatalneurodegenerative
diseases that affect humans, cervids, bovids, and ovids. According to the protein only hypothesis, the
causative agent of prion diseases is a misfolded, abnormal isoform of a normal, host-encoded protein
1.
Termed PrP
C, this 30–35 kDa glycoprotein is expressed most abundantly in the central nervous (CNS) and
lymphoreticular systems, with lower expression in other tissues. The absolute requirement of PrP
C expression to
generate prion diseases
2 and the lack of instructional nucleic acid make prions unique among infectious agents.
The pathologic, protease-resistant isoform (PrP
Sc) typically accumulates in the CNS and secondary lymphoid
tissuesofinfectedanimals.Uponneuroinvasion,priondiseasestypicallyprogressfromtransformationofPrP
Cto
PrP
Sc to neuropathology including amyloid plaque formation, astrogliosis, and neuronal cell loss to inevitable
death.
Before prions accumulate on follicular dendritic cells (FDCs) in secondary lymphoid organs (SLOs)
3,4, they
most likely interact with the innate immune system at the initial site of infection. Complement proteins like C3
and C1q are important innate immune molecules shown to bind foreign bodies and altered-self-particles
5,
including protein amyloids
6 and high density prion protein
7. C1q, C3 and the Complement receptor CD21/35
havebeenshowntoexpediteperipherally-inducedprionpathogenesis
8–10.Thesedatasuggestthatinitialeventsin
prioninfectionincludeComplementopsonizationandinflammatoryimmunecelluptakeandtransportofprions
frominitialinfectionsitestodraininglymphnodes,whereperipheralprionreplicationoccurs.Complementmay
bindprionsandenhanceuptakebyantigenpresentingcells,aswellasretentionandreplicationofprionsonFDCs
in germinal centers.
Solublecomplementproteinsopsonizepathogensandfacilitatetheiruptakebyimmunecellssuchasdendritic
cells (DCs), macrophages (MWs), and monocytes surveying nonlymphoid tissues. These innate immune res-
ponses represent the first line of defense against invading pathogens. Because these immune cells act as sentinels
for microbial infections, investigators have implicated them as likely candidates for the uptake and spread of
prions throughout the body. Indeed, DCs, MWs, and monocytes have been reported to both positively and
negatively impact prion disease pathogenesis
8,9.
Although substantial evidence links immune cells to prion disease, little data directly support a role for these
cells in uptake and transport of prions hours after initial exposure. Because incunabular interactions between
pathogens and immune cells often dictate the outcome of infection, insight into interactions of prions with the
mononuclear phagocyte system at initial infection sites and within lymph nodes is vital to understanding
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inflammatory response to prions that occurs within hours of infec-
tion, including lymphotropic and intranodal prion trafficking.
Results
Enrichment and fluorochrome conjugation of aggregated prion
rods. In order to monitor prion trafficking from inoculation sites to
draining lymph nodes, we first enriched prion rods from a brain of an
elk terminally sick with CWD from one liter of 10% crude brain
homogenate, concentrating prion aggregate volume 10
4-fold to a
final volume of 100 ml using detergent solubilization and ultra-
centrifugation through a sucrose cushion (figure 1A). We enriched
aggregated prion rods approximately 10
3-fold (compare lanes 1 and
2 to 3 and 4). Like the crude brain homogenate, purified prion
rods showed partial PK resistance (lanes 2 and 4). Normal brain
homogenate contained no PK-resistant PrP
C bands (lane 6).
Intracranial injection of 1 mg of enriched, sonicated prion aggregates
resulted in terminal disease in susceptible mice 122 6 5( n 55) days
post inoculation (DPI) compared to 157 6 16 DPI for mice inoculated
with 30 mg of 1% crude brain homogenate (n58, p5.0003). We then
conjugated enriched prions to Dylight 649 fluorochrome (figure 1B).
To evaluate the stability of the fluorochrome, we treated conjugated
prions with PK (figure 1B, lanes 2 and 3) at physiological (lane 2) or
supraphysiological temperatures (lane 3). DyLight 649 still fluoresced
even after SDS and PK treatment followed by incubation at 95uC. In
addition to demonstrating partial SDS and PK resistance (lanes 2 and
3), fluorescent prions could also aggregate into high molecular weight
oligomers (lane 1).
Prion trafficking in live animals. Resistance of fluorochrome
conjugated prion rods to proteolytic and thermal degradation
enabled us to visualize and track these fluorescent prions in vivo
using whole mouse live imaging (Figure 1C). Inoculation of 2 and
5mgofsonicated,fluorescentprionsviasubcutaneous(SC)andperos
(PO) routes, respectively, resulted in prion trafficking to areas
consistent with the location of axillary lymph nodes within
2 hours post inoculation (HPI) PO and 4 HPI SC. Within 8 HPI
SC, prions disseminate to areas consistent with the location of
submandibular lymph nodes, spleen, and bladder. Prion trafficking
from the oral cavity after PO inoculation was restricted primarily to
areas consistent with the location of Peyer’s patches and axillary and
mesenteric lymph nodes. We observed little or no dissemination of
10 mgo f1mm fluorescent polystyrene microspheres (beads) from
their SC injection site, indicating specific trafficking of prion rods.
Figure 1 | Purification and conjugation of prion rods from infected brain homogenate and real-time whole-mouse in vivo imaging. (a) Western blot
analysis depicting CWD infected elk brain homogenate used as starting material (5 mg in lane 1 and 100 mg in lane 2) from which we enriched prion rod
aggregates(100 nginlanes3and4).Lanes5and6show100mgofcontrolelknormalbrainhomogenate.(b)SDSpagegeldepictingfluorochrometagged
prion rods. Prions treated at 37uC without Proteinase K (PK, lane 1) or with PK (lane 2), and at 95uC with PK (lane 3). Molecular weight markers are
shown in kilodaltons to the left of the blots. (c) In vivo detection of prion rods by epifluorescent whole-body optical imaging. Representative images of
tg5037 mice injected orally or subcutaneously with PBS or fluorescent prion rods or 1 mm polystyrene microspheres (beads). Images were acquired at
indicated time points after injection.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 440 | DOI: 10.1038/srep00440 2Immune cells capture prions from the peritoneal cavity 2 HPI.
Particulate antigen can be transported to SLOs via cell dependent and
independent mechanisms
10,11. The presence of prions, but not beads,
in various locations consistent with lymph nodes that drain the
injection site suggested active uptake and trafficking by migratory
immune cells. To investigate this possibility, we first assessed
whether immune cells associated with fluorescent prions hours after
injection. Isolation of adequate cell numbers from subcutaneous tissue
and the oral cavity proved difficult for characterizing innate immune
cells at these injection sites. We therefore chose the peritoneal cavity
(PC) as an alternative inoculation route because it provides an optimal
site for collecting immune cells. We inoculated mice intraperitoneally
(IP) with 5 mg of fluorescent prions, collected cells by peritoneal lavage
2 HPI and analyzed them by flow cytometry (Figures 2 and 3).
DCs and MWs comprise the majority of prion-bearing immune
cells (prionophils) in the PC. We observed significant acquisition of
prions and 10 mgo f1mm fluorescent beads by immune cells present in
Figure 2 | Gatingstrategyforflowcytometry. Sidescatter parameter(SSorSSC)andallother axesarelogscaleexceptforwardscatter (FS).*CD23gate
not shown, but was set identically to the indicated gate. **CD3 gate not shown, but was set identically to the indicated gate. MWsF4/80 and DCsF4/80 cells
were identified using F4/80 gating. pr, prionophilic; MWs, macrophages; DCs, dendritic cells; LN, lymph node; SC, Subcapsulary.
www.nature.com/scientificreports
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the major antigen presenting cells analyzed from the PC,
SSC
hiLy6G
2Ly6C
2CD11b
1CD11c
1 DCs (Figure 2 and 3r) and
SSC
hiLy6G
2Ly6C
2CD11c
2CD11b
1 MWs( F i g u r e2a n d3 s )w e r et h e
predominant cell types capturing prions. Upregulation of CD11c on
inflammatory MWs can complicate their discrimination from DCs.
Figure 3 | FlowcytometricanalysisofimmunecellstraffickingprionsfromthePCtoMedLN2HPI. PBS(rowsa–g,v-ab,ac-ai,andax-bd),fluorescent
beads (h–n, v-ab, aj-ap, and ax-bd) or prion rods (o–u, v-ab, aq-aw, ax-bd) were injected into the PC of mice and cells harvested from peritoneal lavage
fluid(a-ab)ormediastinallymphnodes(ac-bd)twohourslater.GraphsinthefirstcolumnshowcellsfrommicetreatedwithPBS(panelsa,vac,andax),
fluorescent beads (h, v, aj, and ax) and prion rods (panels o, v, aq, and ax). Fluorescent cells (red or green dots) and total cells (grey dots) are plottedt o
showrelative size (forwardscatter, linearscale),granularity (sidescatter, logscale)andproportion oftotallivecellsthat fluoresce. Cellswerealsostained
with antibodies against immune cell surface markers and gated for SSC
hiLy6G- Ly6C1CD11b1 monocytes (panels b, i, p, w, ad, ak, ar, and ay),
SSC
hiLy6G1 Ly6C-CD11c- CD11b1 neutrophils (c, j, q, x, ae, al, as, and az), SSC
hiLy6G- Ly6C-CD11b1CD11c1 DCs (d, k, r, y, af, am, at, ba),
SSC
hiLy6G-Ly6C-CD11c-CD11b1 MWs, (e, l, s, z, ag, an, au, and b), SSC
loB2201CD211CD3- B cells (f, m, t, aa, ah, ao, av, and bc) and SSC
loCD21-
B220- CD31Tcells (g, n,u, ab,ai,ap,aw, andbd).Cell counts ingraphs areshown aslog10per10
5total cells.Horizontal barsbelow the PC andMedLN
panels represent relative proportions of prion-bearing monocytes (red stripe), neutrophils (solid red), DCs (dotted), MWs (checkered), B cells (white)
and T cells (black).
www.nature.com/scientificreports
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performed an alternative gating strategy that gated for SSC
hiLy6C-
Ly6G-F4/801CD11b1 MWsa n dS S C
hiLy6C-Ly6G-F4/80-CD11b1
CD11c1 DCs (Figure 2) to more clearly define these two cell po-
pulations. Both strategies yielded very similar results, and are reported
here as combined data. We detected significant numbers of prionophilic
DCs (prDCs, Figure 3y, median53177; IQR51280 to 33,968 per
100,000 cells, n516 mice) and MWs( prMWs, Figure 3z, median5
14,730, IQR57598 to 29037, n516) compared to DCs and MWs
from mice inoculated with PBS alone (pbsDCs, Figures 3d and y, e
and z, median58, IQR51t o2 0a n dpbsMWs, median54, IQR51t o
7, respectively, n513, p,0.001). prMWs and prDCs accounted for
78.6% and 16.9%, respectively, of total prionophils.
DCs and B cells preferentially capture prions. Comparing two
particulate antigens, we detected three-fold more prDCs (median5
3177) than bead-bound DCs (bDCs, median51037, IQR5479 to
1654, n55, p5 0.0262, Figure 3K and Y). In a subset of mice
whose cells acquired prions, we observed 40-fold more prDCs (6/
16, median541,905. IQR5 31,234 to 59,043, p50.0022) than bDCs.
We observed a small proportion (0.6% of total), yet significant
number, of prionophilic SSC
loB2201CD211CD32 B cells (prB
cells, Figures 2 and 3t and aa, median 5117, IQR584 to 192
p,0.05) in the PC compared to PBS (Figures 3f, and aa, median52;
IQR50 to 10) but little to no bead-bearing B cells (Figures 3m and
AA, median50, IQR50t o7 ,n 55). We detected no significant dif-
ference in numbers of peritoneal prMWs or bead-bearing MWs
(Figure 3l and z, median510,700; IQR59658 to 22,144, n55).
Relatively few Monocytes and Neutrophils capture prion rods
from the PC. SSC
hiLy6G
2Ly6C
1CD11b1 monocytes and
SSC
hiLy6C
2Ly6G
1CD11c
2CD11b
1 neutrophils (Figure 2) also
show a propensity to retain prions from the PC 2 HPI. We
collected significant numbers of prionophilic monocytes (prMonos,
Figure 3p and w, median5638, IQR5276 to 967, n516)
and neutrophils (prNeuts, Figure 3q and x, median577, IQR538
to 9874, n510) compared to PBS inoculated controls (pbsMonos,
Figures 3b and w, c and x, median52; IQR 0 to 10, n513 and
pbsNeuts, median50, IQR 0 to 2, n510; p,0.001). Additionally,
neutrophils exhibited the highest propensity for prion rod uptake,
with upto 98% of neutrophils inPC capturing prions. Still, prMonos
and prNeuts comprised only 3.4% and 0.4%, respectively, of total
prionophils. We also collected significant numbers of bead-
associated monocytes (bMonos, Figure 3i and w, j and x, median5
401, IQR5171 to 4388; p,0.01) and neutrophils (bNeuts, IQR566
to 839; n55, p,0.01) compared to PBS, but observed no difference
in numbers of prMonos/Neuts versus bMonos/Neuts. Finally, We
detected no significant numbers of prionophilic or bead-associated
SSC
loB220-CD21-CD31 T cells (Figure 2, prT and bT cells,
respectively) in the PC at 2 HPI (Figures 3g,n, u and ab). We
observed similar prionophil quantities and proportions from
identical experiments using PrP
C deficient mice (data not shown).
PrionophilsarepresentintheMedLN2HPI.Wethensearchedfor
prionophilsin LNs to whichthese cells migrate. We failed to identify
significant numbers of prionophils in spleens or mesenteric lymph
nodesinthisassay,asexpectedforantigensinjectedIP.However,we
observed significant acquisition of fluorescent prions and beads by
immune cells present in the mediastinal lymph nodes (MedLN) 2
HPI compared to PBS (Figures 3AC, AJ and AQ). We also observed
traffickingtoinguinal lymphnodes,butatlowerfrequenciesandcell
counts compared to MedLNs (data not shown). Confocal micro-
scopy revealed large prion aggregates in areas of MedLNs
consistent with lymphoid follicles and capsules (Figure S1). Intere-
stingly,weobserveddrasticchangesinprionophilproportionsinthe
MedLN compared to the PC.
MWsandBcellscomprisethemajorityprionophilsintheMedLN.
WeobservedmoreprMWsthananyotherimmunecelltypeanalyzed
(Figure 3au and bb, median534, IQR511 to 70 n516, compared to
pbsMWs (Figures ag and bb, median50, IQR50 to 6 and n513,
p,0.001)), consistent with their predominance in the PC.
Surprisingly, though, prB cells represented the second highest
number of prionophils in the MedLN (Figures av and bc,
median523, IQR517 to 32 p,0.01 compared to PBS inoculated
controls). This represents a 44-fold increase in the proportion of
prB cells in the MedLN (26.4%) compared to the PC (0.6%). The
proportion of prMWs decreased 2.1-fold from the MedLN (39.1%)
compared to the PC (78.6%). We detected statistically insignificant
numbers of bMWs (Figure 3an and BB, median56; IQR53 to 61,
n55)andbBcells(Figure3aoandBC,median510,IQR54to26)in
the MedLN.
Increased proportion of monocytes in the MedLN. We collected
half as many prMonos (Figure 3ar and ay median511; IQR 7 to 15;
p,0.05) and prDCs (Figure 3at and ba, median511; IQR56t o4 4
per 10
5 cells, n516 mice) from the MedLN compared to prB cells.
The proportion of prMonos increased 3.7-fold in the MedLN
(12.6%) compared to the PC (3.4%), while prDC proportions
decreased slightly. Interestingly, we detected four-fold more
bMonos (Figure 3ak and ay median545; IQR514 to 105; p,0.01)
than prMonos. We observed no significant difference in the number
of prDCs and bDCs (Figure 3am and ba, median57, IQR53 to 83,
n55), and found no significant numbers of prNeuts (Figure 3as and
az),bNeuts(alandaz),prT(awandbd)orbT(apandbd)cellsinthe
MedLN.
Peritoneal prionophils both internalize and retain prion rods on
their cell surfaces. We assessed subcellular location of captured
prions by visulaizing peritoneal prionophils by confocal
microscopy. While prMonos (Figure 4) and prMWs (Figure S2)
showed a tendency to internalize prion rods, these cells, as well as
prDCs(Figure S3), and prNeuts (Figure S4) demonstrated the ability
to retain prion rods on both the cell surface and intracellular
compartments. Internalized fluorescent prions generally appeared
more diffuse, while cell surface prions appeared as bright, punctate
fluorescent aggregates ranging in size from 1 -3 mm
3 on cell surfaces.
Dynamics of prion trafficking kinetics over time. Most prionophil
proportions in the PC remained relatively constant from 2 to
36 hours (Figure S5), except for a 26-fold increase in prNeuts from
2 (0.4%) to 6 HPI (10.3%). Consistent with data collected 2 HPI, at
6 HPI prB cells increased their proportion 201-fold from the
PC (Figure S6, 0.3%) to the MedLN (60.3%), becoming the
predominant prionophil, while the prMW proportion decrease 6.4-
fold from the PC (70.9%) to the MedLN (11.1%). By 16 HPI, we
observed a relatively even distribution of all prionophils analyzed,
save prNeuts (Figures S5 and S7). The share of prDCs increased 4.4-
fold from the PC to MedLN at 16 HPI, then plateaued to 36 HPI
(Figures S5 and S8). Proportions of prMonos from PC to MedLN
increasedsteadilyovereverytimepoint,reachingitsmaximumshare
of total prionophils in the MedLN at 36 HPI (41.8%). The
distribution of the other prionophils analyzed remained relatively
constant from 16 to 36 HPI, except for prMonos, whose
percentage increased two-fold over that time. We failed to detect
any fluorescent prions or beads one week after inoculation (data
not shown).
PassiveandactivetransportofprionstoMedLNs.Previousstudies
indicate that DC trafficking antigen to draining lymph nodes occurs
12–16 HPI
10–12. Given the early detection of prionophils in the
MedLN in as little as 2 HPI, we postulated passive prion delivery
might occur at early time points whereas active transport by
prionophils may occur later in infection. To test this hypothesis we
www.nature.com/scientificreports
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thePCandMedLNtwohourslater.Peritonealcellsfromdonormice
were washed to remove unbound prions and 10
6 cells transferred
into the PC of each recipient mouse. MedLN from donor and
recipient mice were analyzed for resident and migratory pri-
onophils, respectively.
SSC
hiCD11b1CD1691 subcapsulary sinus MWs (SCS MWs,
Figure5a)isolatedfromdonormiceshowahighpropensityforprion
uptake 2 HPI (Figure 5b (red cloud) and 5d (red dots), median594;
IQR527 to 148 per 100,000 cells, n517 mice, p,0.01) compared to
mice inoculated with PBS (Figure 5b (blue cloud) and 5d (blue
squares, median56; IQR 2 to 7, n53 mice). SSC
hiCD11c1CD8a1
resident DCs also show a significant ability to take up prions
(Figure 5c and 5e (red cloud and dots) median58; IQR 4 to 11,
n517, p,0.05) compared to PBS controls (blue cloud and dots,
median52; IQR 1 to 5, n53).
We assessed active prion transport by isolating cells from the
MedLN of recipient mice inoculated with prion-loaded donor cells.
We detected a small number of prMonos in MedLNs at two HPI
(Figure5f,h,andj,median56IQR54to24)and16HPI(Figure5g,i,
and k, median54 IQR51 to 9). While these median numbers are
low,wediddetect13and181prMonosintwomice,and15prMWsin
one mouse at 16 HPI.
We also performed adoptive transfer experiments at 6 HPI to
analyze MedLN cells for prB cells to assess the drastic increase in
their proportions at this time point. In donor MedLNs we de-
tected significant numbers of prionophilic SSC
loCD5-CD11b-
B2201CD231CD211 follicular B2 cells (prB2, Figure 6b and D,
median524; IQR53 to 40, n55, p50.008). Surprisingly, we also
detected significant numbers of prionophilic SSC
loB220-CD21-
CD23-CD11b1CD51 B1 cells (prB1, Figure 6c and e, median57;
IQR 4 to 21, n57, p50.005) there. MedLNs from recipient mice
contained prB2 (Figure 6g and h, red peak and dots, median5108
per 10
4 B cells, IQR541 to 179, p50.045), but not prB1 (green,
median51, IQR51 to 29) cells 6 HPI.
The role of Complement in prionophil uptake and trafficking
of prions 2 HPI. Complement facilitates prion pathogenesis,
replication and uptake by FDCs and conventional DCs
13–15.T o
examine the interplay of complement with prions in early
inflammatory events involving the MPS, we inoculated mice
deficient in complement components C1q or C3 with prions IP
and analyzed immune cells from the PC and MedLN for prion
retention 2 HPI.
Impaired ability of DCs from Complement deficient mice
to capture prions from the PC. While C1q
2/2 and C3
2/2 mice
possessed similar numbers of total prionophils in the PC, they
exhibited altered prionophil proportions compared to controls
(Figure 7, panels f, k, p, and u). We detected fewer prDCs from
C1q
2/2 (panels 6n and x, median5390; IQR5184 to 1077 n511,
p50.01) or C3
2/2 mice (6s and x, median5913; IQR5165 to 1492
n57, p50.01) than from wt mice (6i and x, median5 3089;
IQR5982 to 33614 n517, p50.001). Concomitantly, we observed
increases in prNeuts from C1q
2/2 (6m and w, median 4006;
IQR5296 to 8508 n511, p50.01) and C3
2/2 (6r and w, median
Figure 4 | Analysisofmonocytes capturingprionrods inthePCby confocalmicroscopy. PBSandprionrods(labeledred)wereinjected intothePCof
mice and CD11b1Ly6C1 (labeled blue and green, respectively) monocytes were analyzed for prion retention. Z stack images were collected at 0.28 mm
intervals and range from 0.64 to 7.31 mm. Image shown in row three, column six indicates isotype and PBS controls. Bottom row starting from the left
show single stains of the nucleus (white), Ly6C, CD11b, and prion rods. The Last 2 panels in the bottom row represent a merged z stack image and an
orthogonal image.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 440 | DOI: 10.1038/srep00440 6Figure 5 | Flow cytometric analysis of passive and active transport of prion rods. Prion rods were injected IP into donor mice and two hours later
immune cells harvested from the PC and mediastinal lymph nodes. Peritoneal cells were washed to remove unbould prion rods and transferred into the
PCofrecipientmice.MedLNfromdonormice2HPI(panelsa–e),andrecipientmice2and16HPI(panelsf–k),wereanalyzedforprion-bearingresident
and migratory immune cells, respectively. Total cells from the MedLN (grey dots in panels a, f and g) are plotted to show relative size (forward scatter,
linear scale), granularity (side scatter, log scale) and proportion of total live cells that bear prions (red dots). Resident MedLN cells were analyzed for
SSC
hiCD11b1CD1691 SCS MWs (b and d) and SSC
hiCD11c1CD8a1 DCs (c and e) bearing prion rods. Prion-loaded cells from donor mice were
injected into the PC of recipient mice and lymph nodes harvested 2 and 16 hours later. Migratory immune cells were also analyzed for monocytes
(depictedasredpeaks(handi)anddots(Jjandk)),DCs(green)andMWs(purple)usingthesamephenotypicmarkersusedinFigure3.Thesecellsubsets
were compared to cells in MedLN from PBS inoculated control mice (blue). Cell counts in graphs d, e, j and k are shown as log10 per 10
5 total cells.
Figure 6 | FlowcytometricanalysisofBcellsubsetsintransportofprionrods. Adoptivetransferexperimentwasperformedsimilarlyasexperimentsin
Figure5.PrionrodswereinjectedIPintodonormiceandsixhourslaterimmunecellsharvestedfromthePCwerewashedandtransferred intothePCof
recipient mice. MedLN from donor (panels a–e) and recipient mice (panels f–h) were analyzed 6 HPI for prion-bearing B1 and B2 cells. Donor MedLN
cells wereanalyzed for SSC
loCD21
1B220
1CD5
2CD11b-CD23
1follicular B2cells (bandd) andSSC
loB220
2CD21
2CD23
2CD11b
1CD5
1B-1 cells (cand
e) bearing prion rods. Recipient MedLNs were also analyzed for prion uptake by B2 cells (red peak (g) and dots (h)) and B1 cells (green). B cell subsets
werecomparedtocellsinMedLNfromPBSinoculatedcontrolmice(blue).Cellcountsingraphsareshownaslog10per10
5totalcells(dande)orper10
4
B cells (h).
www.nature.com/scientificreports
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(6h and w, median 93; IQR542 to 6669 n511, p50.001). Con-
sequently, the proportion of prDCs in the PC decreased 8.4-fold in
C1q
2/2 (Figure 7, pie chart right of panel O, dotted purple wedge)
and two-fold in C3
2/2 mice (dotted green wedge from panel T pie
chart) compared to wt (dotted red wedge from Panel J pie chart),
while prNeut proportions increased 40.6 and 21-fold for C1q
2/2 and
C3
2/2 mice, respectively (compare black wedges in the three pie
charts right of j, o and t). We also detected a two-fold decrease in
prMonos fromC3
2/2 (striped green) but not C1q
2/2(striped purple)
mice compared to wt (striped red). We detected no significant
proportional changes in prMWs (solid colored wedges), which
remained the predominant prion scavenger in the PC of wt (j and
y), C1q
2/2 (o and y) and C3
2/2 (t and y) mice.
Impaired ability of DCs from Complement deficient mice to
capture prions in the MedLN. Surprisingly, we detected more
prionophils in MedLNs from both C1q
2/2 (Figure 7 panels aj and
at) and C3
2/2 (ao and at) mice compared to wt mice (panels ae and
at). However, consistent with data derived from the PC, we observed
an approximately four-fold reduction in the proportion of prDCs in
both C1q
2/2 (dotted purple wedge from pie chart right of an) and
C3
2/2(dottedgreenwedgeinchartrightofas)MedLNscomparedto
wt (dotted red wedge, chart right of ai).
Also consistent with PC data, prMWs from wt (ai and ax, me-
dian536; IQR511 to 90 n517, p50.01), C1q
2/2 (an and ax, me-
dian5161;IQR5123to333n511,p50.001)andC3
2/2mice(asand
ax, median5137; IQR537 to 419 n57, p50.001) constitute the
majority of immune cells involved in prion uptake. We observed
increases in both raw numbers (ax) and proportions of prMWs from
C1q
2/2 and C3
2/2 mice compared to wt (compare solid colored
wedges from the pie charts to the right of panels ai, an and as).
Relative proportions of prMonos (striped purple, green and red
wedges), prNeuts (black wedges) and prB cells (data not shown)
remained similar in C1q
2/2, C3
2/2 and wt MedLNs.
Discussion
In order to gain insight into incunabular immunological events in
prion infection, when the innate immune system initially confronts
prions, we used highly enriched, fluorochrome conjugated prions to
document prion trafficking and immune cell confrontation hours
after initial exposure. We attempted to model prion trafficking as
closely to a natural infection as possible using nonsaturating
amounts of highly enriched, heterogeneously-sized, bona fide infec-
tious prions. Fluorochrome conjugation of enriched prions elimi-
nated detection using anti-prion protein antibodies, which cross-
react with endogenous PrP
C and complicate data interpretation.
Many studies suggest a role for MWs and CD11c
1 DCs in the
capture, degradation and/or transport of prions
8,9,16–23. Consistent
with these previous data, prMWs and prDCs comprised the vast
majority of prionophils detected in the PC 2 HPI, while prMonos,
prB cells and prNeuts comprised the remaining small fraction. Only
DCs and B cells preferentially captured prions over beads, evincing
receptor mediated capture by these cells, perhaps by innate immune
receptors as previously suggested
7,13,15,24.
Based on current paradigms of cell-mediated trafficking of
antigens
10,25–27, including prions
22,24, from infection sites to draining
lymph nodes, we expected to find few prionophils in the MedLN
before 16 HPI. Instead, we found considerable numbers of prMWs,
prMonos, prDCs and, strikingly, huge increases in prB cell
proportions well before then. These data raise the strong possibility
that a considerable portion of prions that we injected IP passively
traveledthroughlymphaticsdrainingthePC,arrivinginMedLNsvia
afferent lymphatics and captured by resident immune cells, as has
been observed for other free antigens
10,26,28. We substantiated this
possibility for prions by identifying significant numbers of priono-
philic resident DCs, SCS MWs, innate B1 and follicular B2 cells in
MedLNs 2 to 6 HPI. Adoptive transfer experiments revealed a small
numberofmonocytesandB2cells,butnotmigratoryDCs,MWsand
B1 cells, pre-loaded with prions from donor mice, present in
MedLNs of recipient mice at these times. We assert that the very
small number of monocytes are not likely to transport the large
amount of prions to MedLNs and transfer them to very large num-
bersofSCMWsthere.Thesedatacompellinglysupportamechanism
of cell autonomous movement of smaller prion aggregates from the
infection site to draining lymph nodes.
Data supporting a cell autonomous route of lymphotropic prion
trafficking also lends insight into intranodal prion movement. The
incredible proportion of prB cells in MedLNs at early time points
indicates that B cells are most likely receiving prions from other
immunecells,probablySCSMWsandresidentDCswithinthelymph
nodes, consistent with current models of intranodal antigen traffick-
ing
26,29.Bcellsarelikelynottheonlycellsreceivingprionsfromother
cells in the LN. FDCs, which trap and replicate prions in germinal
centers, originate from stromal cells and are sessile, permanent resi-
dents in LNs
30,31. Thus, they must receive prions intranodally from
anothersource,perhapsprBcellsorbydirectlycapturingsmallprion
aggregates arriving in the LN through follicular conduits. We also
reproducibly observed a considerable proportion of prT cells in
MedLNs but not in the PC, at all time points, further supporting
intranodal, intercellular prion transfer. Future experiments docu-
menting intranodal prion trafficking in real time using multiphoton
intravital microscopy will confirm this hypothesis.
NumerousstudiescorroboratethefacilitativeroleofComplement
in peripheral prion pathogenesis. In this study we found that fewer
DCs captured prions without C1q or C3 and fewer monocytes cap-
tured prions without C3, while neutrophil capture dramatically
increased in the PC. MWs predominantly and efficiently captured
prions seemingly independent of C1q and C3. We interpret these
data to reveal that DCs and monocytes require C1q and/or C3 for
optimal prion retention, perhaps through Complement receptors
like Mac-1, SIGN-R1 or Calreticulin
7,28. The neurotoxic prion pep-
tide PrP106–126 has been shown to bind the G protein-coupled recep-
tor, formyl peptide receptor-like 1 (FPRL-1) on, and enhance
proinflammatory cytokine production from monocytes
32. Prions
bindingFPRL-1onmonocytescouldexplainthisprionophil’sappar-
ently reduced dependence on Complement for prion capture.
Based on the data described here, we propose an updated, more
detailed model of lymphotropic and intranodal prion trafficking by
immune cells (Figure 8). Biphasic lymphotropic transport of prions
occurs from the initial entry site upon peripheral prion infection. A
first wave of smaller prion aggregates passively percolate through
interstitia, and collect into and quickly travel through the lymphatic
system to draining lymph nodes. A small number of monocytes also
rapidly and actively transport larger prion aggregates. SCS MWs
capture free prions as they emerge from afferent lymphatic vessels,
while resident DCs extend processes into follicular conduits and
extract free prions. MWs at the site of infection capture large and
smallaggregateswithorwithoutComplement,perhapsbyscavenger
or other phagocytic receptors, or even macropinocytosis. These
Figure 7 | Flowcytometricanalysisofimmunecellstraffickingprionsincomplementdeficientmice. FigurepanelsarearrangedsimilarlyasinFigure4.
Piechartstotherightoftheflowcytographsofprionophilsfromwt(f–j),C1q
2/2(k–o)andC3
2/2(p–t)micerepresentrelativefrequenciesofprionophils.
Pie chart wedges depict MWs from wt (red), C1q
2/2 (purple), and C3
2/2 (green) mice, DCs from wt (dotted red), C1q
2/2 (dotted purple), and C3
2/2
(dottedgreen)mice,monocytesfromwt(stripedred),C1q
2/2(stripedpurple),andC3
2/2(stripedgreen)mice,andneutrophils(black)fromwt,C1q
2/2,
and C3
2/2 mice.
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ity of prions, whereas DCs and monocytes preferentially retain
Complement-opsonized prions on their cell surfaces via Com-
plement receptors. These prDCs and prMonos deliver the second
wave of prions to draining LNs at least 12 hours later.
Inside LNs, SCS MWs capture free prions or receive them from
incoming prDCs and prMonos. prDCs or SCS prMWs (which are
more prone to present antigen than phagocytic peripheral prMWs)
transfer prions to follicular B2 cells (and perhaps a few T cells), most
likely but not necessarily aided by Complement. prB2 cells then
shuttle prions from the SCS or follicular conduits to FDCs, which
express copious amounts of PrP
C that is converted into PrP
Sc in this
optimizedprionbioreactor.Cellautonomousprionsnotcapturedby
SCS MWs or resident DCs may encounter follicular B2 cells at fol-
licular conduit termini or travel deep into the follicle where FDCs
directly bind them. While prion replication certainly requires PrP
C,
incunabular prion capture and trafficking does not.
Methods
Mice.PrP
2/2(C57BL/6X129sv),Tg(cerPrP)5037andC1q
2/2miceweregeneratedas
previously described
33–35. FVB, and C3
2/2 (C3tm1Crr/J) mice were purchased from
TheJacksonLaboratory(BarHarbor,ME).AllmicewerebredandmaintainedatLab
AnimalResources,accreditedbytheAssociationforAssessmentandAccreditationof
Lab Animal Care International, in accordance with protocols approved by the
Institutional Animal Care and Use Committee at Colorado State University.
Fluorescent Prions. Enrichment and fluorochrome labeling of prions were
performed as previously described
36–38 with slight modifications. 10% Elk brain
homogenate prepared in 0.32 M sucrose, 150 uM NaCl, 4 uM EDTA diluted in PBS
(PMCA buffer) were centrifuged at 3,000 g for 10 minutes at 4u. The resulting
supernatant were removed and saved and the pellet treated in PMCA buffer then
centrifugedagainat3,000 gfor10minutesat4uC.Supernatantswerethenpooledand
centrifuged at 100,000 g for 1 hr at 4uC and the resulting pellet treated with triton
X-100 at 0uC at a final detergent concentration of 2% wt/vol, bringing the protein
concentration to 5 mg/ml in TBS measured by the Bradford assay. The sample was
thenchilled onice for30minutes and centrifuged at100,000 g for30minutes at 0uC.
Thepelletwasthenwashedtwiceat0uCin10 mMTrisHCL,0.1NaCl,1 mMEDTA,
5 mM PMSF at a pH of 7.4 with and without 2% Triton X-100. The supernatant was
discarded and the pellet resuspended in PBS containing 1% (wt/vol) sarcosyl and
protease inhibitors and stirred for 2 hours at 37uC before centrifuging through
0.32 M sucrose in PBS at 100,000 g for 60 minutes at 10uC. The pellet was
resuspended in a 2.3 M NACl, 5% sarcosyl solution and sonicated 5 times at 40
second bursts. The fractions were centrifuged at 13,000 g for 15 minutes at 4uC,
washed twice with TBS and stored at 270uC or conjugated to Dylight 649 using the
Dylight Antibody Labeling Kit according to manufacturere’s protocol (Thermo
Scientific Pierce).
PKdigestionandwesternblotting.Samplesweredigestedwith50mg/mlPK(Roche)
for 30 min at 37uC. The reaction was stopped by adding lithium dodecyl sulfate
sample loading buffer (Invitrogen) and incubating at 95uC for 5 min. Proteins were
electrophoretically separated through 12% sodium dodecyl sulfate-polyacrylamide
gels (Invitrogen), and transferred to polyvinylidene difluoride membranes
(Millipore). Non-specific membrane binding was blocked by incubation in 5% milk
blocking solution (Bio-Rad) for 1 h. Membraneswere thenincubated for1 h at room
temperature with horseradish peroxidase-conjugated Bar224 anti-PrP monoclonal
antibody (SPI bio) diluted 1520,000 in Superblock (Pierce), washed 6 X10 min in
Figure 8 | PrionTraffickingModel. ImmunecellsencounterprionsinthePCandMedLN.Mw,DCs,monocytes,neutrophils,BandTcellshaveallbeen
shown to associate with prions in the PC and MedLN early after infection. Small prion particles traffic passively through the lymphatic system and enter
the lymph node through afferent lymphatic vessels where they encounter B cells through follicular conduits. DCs may also access prions through
protrusion of their dendrites through tight junctions into follicular conduits. SCS Mws trap larger prion or prion-complement immune complexes
throughscavengerorcomplementreceptor3andmaypresentthemtounderlyingfollicularBcells.Inflammatorymonocytesactivelytransportprionsto
SCS Mws, B cells, or DCs in the draining lymph node. B cells facilitate intrafollicular prion trafficking to FDCs for efficient prion replication.
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substrate (Millipore). Membranes were digitally photographed using the FujiDoc gel
documentation system equipped with a cooled charge-coupled diode camera (Fuji).
Prion Inoculations. Prion Inoculations were performed as previously described
37,38.
Briefly, ice were inoculated IP with 100ml of PBS, or various concentrations of red
fluorescent microspheres(Flourophex) orasuspension ofprionaggregatesdescribed
above.
Live animal imaging. Mice were inoculated SC and PO with indicated amounts of
fluorescentbeadsorprions,and visualizedwhileanesthetizedwith3 L/minIsofluorane
in an IVIS 100 live animal imager (Caliper Life Sciences,Hopkinton, MA) at the
indicated time points. We analyzed images using Living Image 4.0 software (Caliper).
Intraperitoneal wash. Immediately after euthanization of mice by C02 asphyxiation
10 ml of PBS was injected into the peritoneal cavity of each mouse using a 12 ml
syringe and 25 gauge x 1/2 in polypropylene hub hypodermic needle. The mice were
setonarockerorgentlyrockedmanuallyfor2minutes.AsmuchPBSaspossiblewas
recovered using the same 12 ml syringe and a 16 gauge X 1K in polypropylene hub
hypodermic needle.
The peritoneal wash fluid was collected in a 15 ml conical tube (Falcon) and
centrifuged at 250 x g for five minutes. The supernatant was discarded and the pellet
re-suspended in 1 ml fluorescence activated cell sorting (FACS) buffer and trans-
ferred to a 1.5 ml eppendorf tube for staining.
Isolationofcellsfromtissues.Followingintraperitonealwashthemediastinallymph
nodes (and where appropriate inguinal, spleen and mesenteric lymph nodes) were
removed from the mice. Lymph nodes were stored in 1 ml RMPI medium on ice for
nolonger than30 min prior toseparation of cells. Thelymph nodes weretransferred
to a 40 mm nylon cell strainer (Falcon ref 352340) with 1–3 ml PBS. Lymph nodes
werepressed through the screen with the plungerof a sterile 1 ml syringe. Loose cells
were rinsed through the screen with an additional 1–2 ml PBS and the filtrate was
transferred to a 15 ml conical tube. The plate was washed with 4–6 ml of PBS and
transferred to the same 15 ml conical. The 15 ml conical containing the single cell
suspension from the lymph node was spun at 1000 rpm for 5 min. The supernatant
was discarded and the pellet re-suspended in 1 ml FACS buffer and transferred to a
1.5 ml eppendorf tube for staining.
Antibody staining of cells. 10
6 cells were aliquoted from single cell suspensions and
pelletedat250xgfor5minutesonabenchtopcentrifuge.Sampleswerewashedtwice
inFACSbuffer(0.1%BSA,10 mMEDTAin1XPBS)byresuspendingthecellpelletin
1 ml FACS followed by centrifugation at 1000 rpm for 5 minutes. Fc receptors were
blocked using 2 ng/ml solution of Purified rat anti-mouse CD16/CD32
(BDPharmingen)andincubatedonicefor20 min.Fcblockwasremovedbywashing
once with FACS buffer before staining solution was added to cell pellets. Cell pellets
were stained using 50 ul of a 1 ng/mL solution of the antibodies listed in Table S1.
Cells were washed twice following staining to remove unbound antibody and red
blood cells were lysed by adding 1 ml of ACK buffer (150 mM NH4Cl, 10 mM
KHCO3,0.1 mMEDTA)tothe cellpelletandimmediatelycentrifugingat250xgfor
5 minutes. The supernatant was removed and cell pellets were resuspended in 1X
FACS for analysis.
Confocal Microscopy. Antibody-stained peritoneal cells were cytospun onto glass
slides and mounted with ProLong Gold medium (Life Technologies, Grand Island,
NY) and dried overnight at 4uC. We acquired images with a LSM 510 Meta confocal
microscope and software (Zeiss).
Flow cytometric and statistical analyses. Flow cytometry data was acquired using a
DakoCytomation CyAnADP flow cytometer and analyzed using FlowJo version 8
(Tree Star, Ashland, OR). Nonparametric statistical analyses were performed using
GraphPad Prism 5 (La Jolla, CA).
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